Group 1 - The A-share market showed mixed performance with the Shanghai Composite Index up 0.21% at 3451.69 points, while the Shenzhen Component and ChiNext Index fell by 0.32% and 0.58% respectively, with a half-day trading volume of 981.32 billion yuan [1] - The pig price has been declining since Q2 2024, with an increase in both breeding sows and newborn piglets, leading to a potential negative impact on CPI if prices continue to drop, prompting government regulatory concerns [1] - According to Zhongtai Securities, the current market conditions suggest that the stock price of the pig sector is at a bottom level, with low risks of further decline, indicating that any minor positive news could trigger significant price increases [1] Group 2 - Huayuan Securities highlighted that agriculture, as a fundamental sector, is experiencing a rise in investment value due to its unique attributes such as "anti-cyclical asset premium" and "historically low valuations" [2] - The investment approach in the pig sector is shifting from a "cyclical thinking" to a focus on "quality and price," with leading companies expected to have strong profit certainty by 2025 [2] - The Agricultural 50 ETF (516810) closely tracks the CSI Agricultural Theme Index, covering various segments including breeding, agricultural chemicals, and feed, with the top ten weighted stocks accounting for over 60% [2]

Group 1 - The report highlights a resilient actual GDP growth forecast of over 5% for Q2 2025, despite nominal GDP pressures due to declining economic data, particularly in real estate investment [6][7] - The report emphasizes the importance of domestic demand and technology as key investment themes, especially in light of the upcoming political bureau meeting that will outline economic policies for the second half of the year [7][8] - The agricultural sector, particularly pig farming, is expected to see a price increase due to reduced supply pressure and improved profitability, with specific companies like Muyuan Foods and Wens Foodstuffs recommended for investment [8][9][10] Group 2 - The pharmaceutical and biotechnology sector is gradually stabilizing, with a reported revenue of CNY 795.03 billion in the first four months of 2025, a year-on-year decline of 2.1% [12][13] - The report notes a significant increase in the number of innovative drug projects and collaborations, with 51 innovative drug projects worth over USD 48 billion completed in the first five months of 2025 [13][14] - Investment recommendations include focusing on innovative drug companies with differentiated products and strong potential for international expansion, such as Kelun Pharmaceutical and Betta Pharmaceuticals [14][27] Group 3 - The basic chemical sector is experiencing a recovery, with the SW basic chemical index outperforming the market, driven by a decrease in raw material costs and potential supply-side reforms [16][17] - Companies with strong cost advantages and those involved in supply-side reforms, such as Hoshine Silicon Industry and Zhejiang Longsheng, are highlighted as potential investment opportunities [18][19] - The report also points to new consumer trends driving demand for health additives and domestic substitutes in the chemical materials sector, with companies like Jinfa Technology and Shengquan Group recommended for investment [19] Group 4 - The electronics sector is witnessing a recovery, with Xiaomi's launch of its first AI glasses and other innovative products expected to strengthen its market position [20][21] - The report indicates a 4.61% increase in the electronic index, outperforming the broader market, with specific focus on AI-driven sectors and semiconductor equipment as key investment areas [22][23] - Recommended companies include companies benefiting from strong domestic and international demand in the AIOT field, such as Espressif Systems and Rockchip Electronics [23] Group 5 - The GLP-1 drug market is gaining attention with the approval of the first dual-target weight loss drug in China, which is expected to drive further interest in the sector [24][26] - The report notes that the pharmaceutical sector's overall performance has been mixed, with a 1.60% increase in the biopharmaceutical index, but specific segments like medical services and devices are performing well [25][27] - Investment suggestions include focusing on companies involved in innovative drug development and medical devices, such as Betta Pharmaceuticals and Yao Ming Pharmaceutical [27][28]

Group 1 - Kanghong Pharmaceutical received a drug registration certificate for Lifisig Eye Drops, approved for treating dry eye symptoms [1] - Kanghong Biotech, a wholly-owned subsidiary, received clinical trial approval for KH813 injection for metastatic non-squamous non-small cell lung cancer [1] - Kanghong Pharmaceutical was established in October 1996, focusing on drug and medical device research, production, and sales [1] Group 2 - Guoyuyuan's subsidiary received a government subsidy of 7.5521 million yuan, accounting for 10.14% of the company's audited net profit for 2024 [2] - Guoyuyuan was founded in November 1996, specializing in drug research, production, and sales [3] Group 3 - Haicheng Bonda's subsidiary signed a lease termination agreement, incurring a termination fee of 3.35 million USD [4] - Haicheng Bonda was established in December 2009, providing comprehensive modern logistics services [4] Group 4 - Hongxin Electronics' subsidiary signed contracts totaling 373 million yuan for computing power business [5] - Hongxin Electronics was founded in September 2003, focusing on FPC research, design, manufacturing, and sales [6] Group 5 - Tianbang Food reached a settlement agreement regarding a 1.214 billion yuan lawsuit, agreeing to repay 410 million yuan over 36 months [8] - Tianbang Food was established in September 1996, specializing in pig farming and pork processing [9] Group 6 - Daoshi Technology's controlling shareholder plans to reduce holdings by up to 1.97% of the company's shares [10] - Daoshi Technology was founded in September 2007, focusing on ceramic color glazes and related products [10] Group 7 - Jinpu Titanium is planning a major asset restructuring, leading to a stock suspension [10] - Jinpu Titanium was established in November 1989, specializing in titanium dioxide production and sales [11] Group 8 - Shenzhen Energy plans to invest 6.332 billion yuan in upgrading the Mawan Power Plant [12] - Shenzhen Energy was founded in August 1993, focusing on conventional and renewable energy development [13] Group 9 - Lihua Co. plans to reduce holdings by up to 3% of the company's shares [14] - Lihua Co. was established in June 1997, specializing in the breeding and sales of poultry [15] Group 10 - China Communications Construction Company plans to repurchase shares worth 500 million to 1 billion yuan [16] - China Communications Construction Company was founded in October 2006, focusing on infrastructure design and construction [17] Group 11 - Huatiankeji's subsidiary received a government subsidy of 80.6569 million yuan, accounting for 13.09% of the company's latest audited net profit [20] - Huatiankeji was established in December 2003, specializing in integrated circuit packaging and testing [21] Group 12 - Luxin Chuangtou plans to acquire shares in Hongke Electronics for a total of 9 million yuan [23] - Luxin Chuangtou was founded in November 1993, focusing on venture capital and industrial development [24] Group 13 - Feilong Co.'s controlling shareholder plans to reduce holdings by up to 563,250 shares [25] - Feilong Co. was established in January 2001, specializing in thermal management components for automotive and civil applications [26] Group 14 - Linglong Tire submitted an application for H-share listing on the Hong Kong Stock Exchange [27] - Linglong Tire was founded in June 1994, focusing on tire design, development, manufacturing, and sales [27] Group 15 - Saiwei Electronics plans to acquire 9.5% of its subsidiary's shares for up to 324 million yuan [28] - Saiwei Electronics was established in May 2008, focusing on MEMS chip development and semiconductor equipment [28] Group 16 - Suzhou Bank's major shareholder plans to increase holdings by no less than 400 million yuan [29] - Suzhou Bank was founded in December 2004, focusing on various banking services [29]

投资咨询业务资格：证监许可【2012】669号 中信期货研究|农业策略⽇报 2025-07-01 ⽉末缩量，⽣猪期现背离 油脂：昨日震荡偏空，关注技术支撑有效性 蛋⽩粕：下游成交缩量，⾖粕延续震荡⾛势 ⽟⽶/淀粉：进⼝拍卖落地，现货依旧坚挺 ⽣猪：⽉末缩量，期现背离 橡㬵：上行驱动有限，胶价横盘震荡 合成橡㬵：盘面跟涨幅度有限 纸浆：基本面弱势不改，纸浆期货维持弱势运行 棉花：冲高回落，棉价减仓下跌 ⽩糖：外盘⽌跌企稳，内盘震荡反弹 原⽊：交割博弈收尾，盘⾯震荡回落 风险因素：宏观大幅变动；气候异常；供需超预期变化 【异动品种】 ⽣猪观点：⽉末缩量，期现背离 主要逻辑：月末养殖场出栏节奏放缓，现货上涨，但期货盘面依旧面 临高产能、高库存压力，期现走势背离。（1）供应：短期，6月集团 场配合降重，行业出栏均重仍在持续下降中，但散户仍有压栏心态， 本周育肥栏舍利用率小幅增加。中期，2025年1月~5月新生仔猪数量 持续增加，按照仔猪→商品猪6个月出栏时间推算，预计下半年生猪 出栏量仍有增长趋势。长期，当前产能仍在高位，据农业部口径， 全国能繁母猪存栏在2024年底增至高点后，2025年一季度母猪产能在 高位波动。 ...

研究早观点 2025 年 7 月 1 日 星期二 市场走势 资料来源：最闻 执业登记编码：S0760521050001 电话：010-83496307 邮箱：lizhaoqi@sxzq.com 【今日要点】 国内市场主要指数 | 指数 | | 收盘 | 涨跌幅% | | | --- | --- | --- | --- | --- | | 上证指数 | | 3,444.43 | 0.59 | 供需情况有望改善 | | 深证成指 | | 10,465.12 | 0.83 | | | 沪深 | 300 | 3,936.08 | 0.37 | | | 中小板指 | | 6,528.34 | 0.87 | | | 创业板指 | | 2,153.01 | 1.35 | | | 科创 | 50 | 1,003.41 | 1.54 | | | 资料来源：最闻 | | | | | 分析师： 李召麒 【宏观策略】海外市场周观察（20250623~20250629） 【山证农业】农业行业周报（2025.06.23-2025.06.29）-看好海大集团的投资 机会 【行业评论】化学制药：创新药动态更新：BGB-43395：在既往三线 ...

联合研究丨组合推荐 [Table_Title] 大消费行业 2025 年 7 月金股推荐 %% %% %% %% research.95579.com 1 丨证券研究报告丨 报告要点 [Table_Summary] 长江大消费九大优势行业（农业、零售、社服、汽车、纺服、轻工、食品、家电、医药）2025 年 7 月重点推荐金股。 分析师及联系人 [Table_Author] 陈佳 李锦 赵刚 SAC：S0490513080003 SAC：S0490514080004 SAC：S0490517020001 SFC：BQT624 SFC：BUV258 SFC：BUX176 高伊楠 于旭辉 蔡方羿 SAC：S0490517060001 SAC：S0490518020002 SAC：S0490516060001 SFC：BUW101 SFC：BUU942 SFC：BUV463 董思远 陈亮 彭英骐 SAC：S0490517070016 SAC：S0490517070017 SAC：S0490524030005 SFC：BQK487 SFC：BUW408 SFC：BUZ392 请阅读最后评级说明和重要声明 2 / 11 ...

2025 年 06 月 30 日 行业研究 评级：推荐(维持) 研究所： 证券分析师： 程一胜 S0350521070001 chengys01@ghzq.com.cn 证券分析师： 熊子兴 S0350522100002 xiongzx@ghzq.com.cn 证券分析师： 王思言 S0350524010001 wangsy02@ghzq.com.cn | 行业相对表现 | | | 2025/06/27 | | --- | --- | --- | --- | | 表现 | 1M | 3M | 12M | | 农林牧渔 | 0.9% | 3.5% | 7.1% | | 沪深 300 | 2.1% | -0.3% | 13.5% | 相关报告 《农林牧渔行业周报：生猪或迎猪价和政策拐点叠 加，布局底部（推荐）*农林牧渔*程一胜，熊子兴， 王思言》——2025-06-09 《农林牧渔行业周报：618 宠物经济火热，国产品 牌强势崛起（推荐）*农林牧渔*程一胜，熊子兴， 王思言》——2025-05-26 《农林牧渔行业周报：宠物经济火热，长期看好国 产品牌发展（推荐）*农林牧渔*程一胜，熊子兴， 王思言》——2025 ...

农业行业2025年中期投资策略： 大畜牧养殖板块有望迎来景气共 振，新消费乘势而上 2025年6月30日 证券研究报告 * 请务必阅读最后一页免责声明 * 01 徐菁、杜海路 ➢ 【牛肉】：我国的牛周期发生了深刻的变化。在过去十年的时间里，肉牛产能扩张速度远低于中国居民牛肉消费增速，因此我国的牛周期表现并不典型，价 格呈现长期趋势性增长的态势。但随着非洲猪瘟后肉类蛋白消费转移、公共卫生事件结束后复产复工带来消费增长，肉牛养殖的高景气周期导致下游激进扩 产，叠加进口量激增，2023年7月起我国肉牛养殖出现了少有的大面积亏损。同时由于肉牛养殖本身行业集中度和规模化水平较低，存在较为严重的信息不 对称，类似于非洲猪瘟前的生猪养殖行业，产能出清速度较快。一旦产能得到有效出清，供需错配和价格弹性极有可能超预期。 ➢ 【新消费】：【宠物】宠物消费市场规模稳步提升，宠物猫消费市场整体维持双位数增长，宠物数量和单宠消费金额均处于量价齐升增长阶段。国产品牌偏 好提升，头部品牌加速增长。国产品牌具备供应链成本价格优势，同等定位、配方产品更具性价比，同时头部品牌凭借本土线上渠道运营、以及双十一、 618大促优势加速崛起，通过品牌营 ...

0 5 10 15 20 25 30 35 40 2021-01 2022-01 2023-01 2024-01 2025-01 生猪均价（元/公斤） 图：生猪均价 资料来源：钢联数据，东海证券研究所 0 100 200 300 400 500 600 700 2022-01 2022-03 2022-05 2022-07 2022-09 2022-11 2023-01 2023-03 2023-05 2023-07 2023-09 2023-11 2024-01 2024-03 2024-05 2024-07 2024-09 2024-11 2025-01 2025-03 2025-05 7KG仔猪价格（元/公斤） 资料来源：钢联数据，东海证券研究所 图：仔猪均价 ● 今年以来生猪价格平稳震荡，仔猪价格先涨后跌。根据钢联数据，6月27日生猪均价14.56元/公斤，年初以来下降7.6%，同比 上升0.9%。春节后至端午节前，生猪价格维持在14-15元/公斤左右震荡，淡季不淡，强于市场预期。主要由于冻品库存下降、 二次育肥增加以及消费需求恢复，支撑猪价。6月以后受集中出栏以及需求季节性偏弱影响，猪价跌破14元/ ...

农林牧渔 行业研究/行业周报 猪价继续反弹，关注种植链投资机会 ——农林牧渔行业周报（20250623-0627） 【农产品】小麦、玉米价格环比上涨，豆粕价格回落。截止 2025 年 6 月 27 日，全国小麦现货均价 2446.39 元/吨，周环比上涨 0.19%；全国 粳稻现货均价 2892.00 元/吨，周环比持平；全国玉米现货均价 2352.86 元/吨，周环比上涨 0.43%。豆粕方面，伴随 5-6 月到港大豆陆续通关， 油厂压榨量攀升，豆粕供应量逐步恢复，豆粕价格回落至 2900-3100 元 /吨之间震荡。截止 2025 年 6 月 27 日，全国豆粕现货均价 2906.00 元 /吨，周环比下跌 3.90%。 ◼ 投资建议 本周农业板块我们建议继续关注种植产业链投资机会，在国际地缘政 治冲突不断升温的背景下，粮食安全也将面临更加严峻的挑战，种植 产业链或成为资金"避险港"，建议关注直接受益于农产品涨价的相关 标的，以及产业链上游种业公司。 ◼ 核心观点 【生猪养殖】低成本是上市猪企穿越猪周期的核心竞争力，重点看好 成本管控相对优秀或降本路径清晰的优质猪企，建议关注：牧原股份、 温氏股份、巨星农 ...